American Journal of Cardiology
Volume 105, Issue 10 , Pages 1371-1377.e1 , 15 May 2010

Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)

  • Antonio Abbate, MD, PhD

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • Corresponding Author InformationCorresponding author: Tel: (804) 828 0513; fax: (360) 323-1204
    • ,
  • Michael C. Kontos, MD

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • John D. Grizzard, MD

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • Giuseppe G.L. Biondi-Zoccai, MD

      Affiliations

    • Division of Cardiology, University of Turin, Turin, Italy
    • ,
  • Benjamin W. Van Tassell, PharmD

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • Roshanak Robati, MD

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • Lenore M. Roach, RN

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • Ross A. Arena, PhD

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • Charlotte S. Roberts, ACNP

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • Amit Varma, MD

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • Christopher C. Gelwix, MD

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • Fadi N. Salloum, PhD

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • Andrea Hastillo, MD

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • Charles A. Dinarello, MD

      Affiliations

    • Department of Internal Medicine, University of Colorado, Aurora, Colorado
    • ,
  • George W. Vetrovec, MD

      Affiliations

    • Virginia Commonwealth University, VCU Pauley Heart Center, Richmond, Virginia
    • ,
  • VCU-ART Investigators (see Appendix)

Received 6 November 2009 ,Revised 22 December 2009 ,Accepted 22 December 2009.

References 

  1. Frangogiannis N. The immune system and cardiac repair. Pharmacol Rev. 2008;58:88–111
  2. Velagaleti R, Pencina M, Murabito J, Wang T, Parikh N, D'Agostino R, et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation. 2008;118:2057–2062
  3. Goldberg R, Spencer F, Yarzebski J, Lessard D, Gore J, Alpert J, et al. 25-Year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Am J Cardiol. 2004;94:1373–1378
  4. Dinarello C. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–550
  5. Pomerantz BJ, Reznikov LL, Harken AH, Dinarello CA. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta. Proc Natl Acad Sci U S A. 2001;98:2871–2876
  6. Bujak M, Frangogiannis N. The role of IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp. 2009;57:165–176
  7. Abbate A, Salloum F, Vecile E, Das A, Hoke N, Straino S, et al. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation. 2008;117:2670–2683
  8. Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A, et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol. 2008;173:57–67
  9. Saraste A, Nekolla S, Schwaiger M. Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability. J Nucl Cardiol. 2008;15:105–117
  10. Gardin J, Adams D, Douglas P, Feigenbaum H, Forst D, Fraser A, et al. Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr. 2002;15:275–290
  11. Braunwald E. Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360–1369
  12. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146
  13. Marino P, Zanolla L, Zardini P. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell‘Infarto Miocardico) trial. J Am Coll Cardiol. 1989;14:1149–1158
  14. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moyé LA, Dagenais GR, et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril. Circulation. 1994;89:68–75
  15. Doughty RN, Whalley GA, Walsh HA, Gamble GD, Lopez-Sendon J, Sharpe N CAPRICORN ECHO Substudy Investigators. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction. Circulation. 2004;109:201–206
  16. GISSI Group. Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study (Gruppo Italiano per lo studio della Streptochinasi nell'Infarto Miocardico (GISSI)). Lancet. 1987;2:871–874
  17. Pfeffer MA, Lamas GE, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319:80–86
  18. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) Group. GISSI 3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343:1115–1122
  19. CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385–1390
  20. Kaplanski G, Porat R, Aiura KErban Jk, Gelfand JA, Dinarello CA. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood. 1993;81:2492–2495
  21. Suzuki k, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, et al. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction of apoptosis. Circulation. 2001;104(Suppl I):I308–I313
  22. Anand I, Florea V, Fisher L. Surrogate end points in heart failure. J Am Coll Cardiol. 2002;39:1414–1421
  23. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RN, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44–51
  24. Crossman D, Morton A, Gunn J, Greenwood J, Hall A, Fox K, et al. Investigation of the effect of interleukin-1 receptor antagonist (IL-1RA) on markers of inflammation in non-ST elevation acute coronary syndromes (the MRC-ILA-HEART Study). Trials. 2008;9:8–14
  25. Furst D. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin Ther. 2004;26:1960–1975
  26. Ikonomidis I, Lekakis JP, Nikolau M, Paraskevaidis I, Andreaudou I, Kaplanoglou T, et al. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation. 2008;117:2662–2669
  27. Orn S, Manhenke C, Ueland T, Dams J, Mollnes T, Edvardsen T, et al. C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. Eur Heart J. 2009;30:1180–1186

 This study was funded by a Virginia Commonwealth University “A.D. Williams Fund” grant to Dr. Abbate and a Virginia Commonwealth University General Clinical Research Center Funds for Pilot Clinical Research to Dr. Abbate, and by the VCU Pauley Heart Center funds (Richmond, Virginia).

PII: S0002-9149(10)00066-4

doi: 10.1016/j.amjcard.2009.12.059

American Journal of Cardiology
Volume 105, Issue 10 , Pages 1371-1377.e1 , 15 May 2010

Article Tools

* Image Usage & Resolution